ctDNA levels
Showing 1 - 25 of >10,000
Breast Cancer Trial in Ulm (Determination of tumormarkers (CA27.29, CEA, CA125), Determination of CTC levels, Determination of
Recruiting
- Breast Cancer
- Determination of tumormarkers (CA27.29, CEA, CA125)
- +3 more
-
Ulm, GermanyUniversity Hospital Ulm Gynecology/Obstetrics
Jan 12, 2023
Metastatic Cancer, Foregut Carcinoid Tumor, Gastric Adenocarcinoma Trial (drug, procedure, radiation, other)
Not yet recruiting
- Metastatic Cancer
- +7 more
- Standard of Care Chemotherapy
- +7 more
- (no location specified)
Apr 1, 2022
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive)
Recruiting
- Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +3 more
- Transoral Surgery
- +8 more
-
New Brunswick, New Jersey
- +2 more
Feb 16, 2022
Head Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oropharynx Cancer Trial in United States (other, radiation, diagnostic
Not yet recruiting
- Head and Neck Cancer
- +4 more
- Experimental Observation
- +3 more
-
Baltimore, Maryland
- +5 more
Oct 16, 2023
Multi-layer Data to Improve Diagnosis, Predict Therapy
Recruiting
- High Grade Ovarian Serous Adenocarcinoma
- WGS and RNA sequencing
- +2 more
-
Turku, FinlandTurku University Hospital
Apr 26, 2022
Melanoma Recurrence With Circulating Tumor DNA (ctDNA)
Active, not recruiting
- Melanoma
-
Murray, Utah
- +1 more
Feb 17, 2023
Improve Organ Preserving Strategies in Rectal Cancer
Recruiting
- Rectal Adenocarcinoma
- +8 more
- Biopsy
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Nov 30, 2022
Circulating Tumor DNA in Pancreatic Cancer UsingPersonalized
Recruiting
- Pancreatic Cancer
- No intervention
-
Kashiwa, JapanNational Cancer Center Hospital East
Sep 12, 2023
Pre-analytical Factors Affecting ctDNA Analysis in Early and
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +4 more
- Biospecimen Collection
- Electronic Health Record Review
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jul 6, 2023
Danish Assessment of Minimal Residual Disease by Liquid Biopsies
Recruiting
- Colorectal Neoplasms
- +5 more
-
Copenhagen, Capital Region Of Denmark, Denmark
- +8 more
Oct 13, 2023
Renal Cancer Trial in Aarhus N
Enrolling by invitation
- Renal Cancer
-
Aarhus N, DenmarkUrology Department Aarhus University Hospital
Nov 21, 2023
Disease Burden, Genetic Heterogeneity and Tumour Evolution in
Recruiting
- Thyroid Cancer
- Sample collection only
-
London, United KingdomThe Royal Marsden NHS Foundation Trust
Apr 28, 2023
Resectable Pancreatic Cancer Trial in Denmark (ctDNA)
Recruiting
- Resectable Pancreatic Cancer
- ctDNA
-
Aalborg, Denmark
- +4 more
Mar 27, 2023
Circulating Tumor DNA Kinetics in Immuno-oncology
Completed
- Head and Neck Cancer
- +4 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
May 16, 2022
Appendix Carcinoma by AJCC V8 Stage, Colorectal Carcinoma by AJCC V8 Stage, Digestive System Tumor Trial in New Brunswick
Recruiting
- Appendix Carcinoma by AJCC V8 Stage
- +6 more
- Biospecimen Collection - blood and tissue sample collection
- Electronic Health Record Review
-
Livingston, New Jersey
- +1 more
Nov 16, 2022
Triple Negative Breast Cancer (TNBC) Trial in United States (Combination of liposomal doxorubicin)
Not yet recruiting
- Triple Negative Breast Cancer (TNBC)
- Combination of liposomal doxorubicin
-
Elizabeth, New Jersey
- +7 more
Jul 13, 2023
Standard Radiotherapy and TMZ Patients With GBM
Not yet recruiting
- Glioblastoma
- Glioma, Malignant
-
Durham, North CarolinaThe Preston Robert Tisch Brain Tumor Center at Duke University
Jan 20, 2023
Circulating Tumor DNA in Locally Advanced Head and Neck Squamous
Suspended
- Head and Neck Neoplasm
- Carcinoma, Squamous Cell
- Blood and tumor samples
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill
Feb 24, 2022
Appendiceal Adenocarcinoma, Colorectal Trial in Houston (Circulating tumoral DNA directed neoadjuvant therapy arm)
Not yet recruiting
- Appendiceal Adenocarcinoma
- Colorectal
- Circulating tumoral DNA directed neoadjuvant therapy arm
-
Houston, TexasM D Anderson Cancer Center
Jul 7, 2023
Bespoke ctDNA Assay for Recurrence and Treatment Response
Recruiting
- Ovarian Cancer
- platinum-sensitive EOC
- platinum-resistant and rEOC
-
Shanghai, Shanghai, ChinaHao Wen
Jul 5, 2022
Metastatic Leiomyosarcoma Biomarker Protocol
Not yet recruiting
- Leiomyosarcoma
- Plasma Collection
-
Rochester, Minnesota
- +2 more
Jan 5, 2023
Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8 Trial (Pulmonary Artery-First Surgical
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- +3 more
- Pulmonary Artery-First Surgical Technique
- Biospecimen Collection
- (no location specified)
Aug 15, 2022
Neuroendocrine Tumors Trial in Belgium (Liquid biopsies, Scans (CT, gallium-68 DOTATE/TOC/NOC PET-CT))
Recruiting
- Neuroendocrine Tumors
- Liquid biopsies
- Scans (CT, gallium-68 DOTATE/TOC/NOC PET-CT)
-
Bornem, Antwerp, Belgium
- +7 more
Jun 1, 2022
Chemoresistance Mechanisms in Pancreatic Cancer
Not yet recruiting
- Patients With Non-metastatic Pancreatic Cancer
- Evaluation of Tumor Resectability Shall be Made in Consensus at Multidisciplinary Meetings, According to NCCN Guideline Version 1.2022 Pancreatic Adenocarcinoma
- ctDNA detection
-
Shanghai, Shanghai, ChinaZhongshan Hospital
Apr 27, 2023